Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
  • Page of 1
Benhabbour RS. Study of Imidazole-Based Proton-Conducting Composite Materials Using Solid-State NMR. Chemistry of materials : a publication of the American Chemical Society. 2005; 17(6):1605-1612. doi: 10.1021/cm048301l.
Benhabbour SR. Synthesis and characterization of carborane functionalized dendronized polymers as potential BNCT agents. Abstracts of Papers. 232nd ACS National Meeting; 2006 September 10; San Fransisco, CA, USA. PMSE-171; c2006.
Benhabbour RS. Synthesis and Properties of Carborane-Containing Dendronized Polymers. Macromolecules. 2007; 40(16):5678-5688. doi: 10.1021/ma0702039.
Benhabbour RS. Protein Resistance of Surfaces Prepared by Chemisorption of Monothiolated Poly(ethylene glycol) to Gold and Dendronization with Aliphatic Polyester Dendrons: Effect of Hydrophilic Dendrons. Macromolecules. 2008; 41(7):2567–2576. doi: 10.1021/ma702074v.
Benhabbour RS. Protein Resistance of Surfaces Prepared by Chemisorption of Mono-Thiolated Poly(ethylene glycol) to Gold and Dendronization with Aliphatic Polyester Dendrons: Effect of Hydrophilic Dendron. Macromolecules. 2008; 41(7):2567-2576. doi: 10.1021/ma8004586.
Benhabbour RS. Synthesis and Characterization of Carborane Functionalized Dendronized Polymers as Potential BNCT Agents. ACS symposium series. American Chemical Society. 2008; 977:238-249. doi: 35400018371493.0140.
Benhabbour SR. Synthesis and characterization of Carborane functionalized Dendronized polymers as potential boron neutron capture therapy agents. In: Polymers for Biomedical Applications USA: ACS Symposium Series; 2008. Chapter 14; p.238-249.
Benhabbour SR, Sheardown H, Adronov A. Cell adhesion and proliferation on hydrophilic dendritically modified surfaces. Biomaterials. 2008 Nov;29(31):4177-86. doi: 10.1016/j.biomaterials.2008.07.016. Epub 2008 Aug 3. PubMed PMID: 18678405.
Parrott MC, Benhabbour SR, Saab C, Lemon JA, Parker S, Valliant JF, Adronov A. Synthesis, radiolabeling, and bio-imaging of high-generation polyester dendrimers. J Am Chem Soc. 2009 Mar 4;131(8):2906-16. doi: 10.1021/ja8078175. PubMed PMID: 19239268.
Benhabbour SR. Engineering of lipid-based nanoparticles with accessible nickel for binding to his-tag protein and antigens. Abstracts of Papers. 239th ACS National Meeting; 2010 March 21; San Fransisco, CA, USA. PMSE-410; c2010.
Feng L, Wu H, Ma P, Mumper RJ, Benhabbour SR. Development and optimization of oil-filled lipid nanoparticles containing docetaxel conjugates designed to control the drug release rate in vitro and in vivo. Int J Nanomedicine. 2011;6:2545-56. doi: 10.2147/IJN.S24954. Epub 2011 Oct 21. PubMed PMID: 22072889; PubMed Central PMCID: PMC3205148.
Benhabbour SR. Targeting of docetaxel-loaded lipid based nanoparticles to breast cancer using a novel trimeric ZEGFR domain. Abstracts of Papers. 243rd ACS National Meeting & Exposition; 2012 March 25; San Diego, CA, USA. PMSE-256; c2012.
Benhabbour SR, Luft JC, Kim D, Jain A, Wadhwa S, Parrott MC, Liu R, DeSimone JM, Mumper RJ. In vitro and in vivo assessment of targeting lipid-based nanoparticles to the epidermal growth factor-receptor (EGFR) using a novel Heptameric ZEGFR domain. J Control Release. 2012 Feb 28;158(1):63-71. doi: 10.1016/j.jconrel.2011.10.013. Epub 2011 Oct 20. PubMed PMID: 22037106; PubMed Central PMCID: PMC3294062.
Ma P, Rahima Benhabbour S, Feng L, Mumper RJ. 2'-Behenoyl-paclitaxel conjugate containing lipid nanoparticles for the treatment of metastatic breast cancer. Cancer Lett. 2013 Jul 1;334(2):253-62. doi: 10.1016/j.canlet.2012.08.009. Epub 2012 Aug 16. PubMed PMID: 22902506; PubMed Central PMCID: PMC3522796.
Feng L, Benhabbour SR, Mumper RJ. Oil-filled lipid nanoparticles containing 2'-(2-bromohexadecanoyl)-docetaxel for the treatment of breast cancer. Adv Healthc Mater. 2013 Nov;2(11):1451-7. doi: 10.1002/adhm.201300017. Epub 2013 Apr 19. PubMed PMID: 23606545; PubMed Central PMCID: PMC3858483.
Peng L, Schorzman AN, Ma P, Madden AJ, Zamboni WC, Benhabbour SR, Mumper RJ. 2'-(2-bromohexadecanoyl)-paclitaxel conjugate nanoparticles for the treatment of non-small cell lung cancer in an orthotopic xenograft mouse model. Int J Nanomedicine. 2014;9:3601-10. doi: 10.2147/IJN.S66040. eCollection 2014. PubMed PMID: 25114529; PubMed Central PMCID: PMC4124067.
Peng L, Feng L, Yuan H, Benhabbour SR, Mumper RJ. Development of a novel orthotopic non-small cell lung cancer model and therapeutic benefit of 2'-(2-bromohexadecanoyl)-docetaxel conjugate nanoparticles. Nanomedicine. 2014 Oct;10(7):1497-506. doi: 10.1016/j.nano.2014.03.016. Epub 2014 Apr 4. PubMed PMID: 24709328; PubMed Central PMCID: PMC4185254.
Benhabbour SR. Development and evaluation of CD44-targeted lipid-based nanoparticles in an orthotopic non-small cell lung cancer xenograft mouse model. 249th ACS National Meeting & Exposition; 2015 March 22; Denver, CO, USA. PMSE-258.; c2015.
What would you like to do?
  • Page of 1